| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |